The role of monocytes in thrombotic diseases: a review

Zhongyu Han1, Qiong Liu1, Hongpeng Li1

  • 1School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Insights

Monocytes, key immune cells, significantly contribute to cardiovascular thrombotic events. Understanding monocyte subsets and their role in thrombosis offers potential new therapeutic strategies for cardiovascular diseases.

Area of Science:

  • Cardiovascular and cerebrovascular diseases research
  • Immunology and thrombosis
  • Innate immunity and cardiovascular health

Background:

  • Cardiovascular and cerebrovascular diseases are leading causes of mortality, with thrombotic events being the most frequent.
  • Thrombosis can precipitate life-threatening conditions like acute coronary syndrome and cerebral infarction.
  • Circulating monocytes, crucial for innate immunity, also play a role in coagulation and anticoagulation processes.

Purpose of the Study:

  • To review the intricate relationship between distinct monocyte subsets and cardiovascular thrombotic events.
  • To elucidate the specific roles of monocytes in arterial thrombosis and their involvement in intravenous thrombolysis.
  • To summarize current understanding of monocyte-thrombosis mechanisms and therapeutic approaches in various cardiovascular conditions.

Main Methods:

  • Literature review focusing on monocyte subsets and thrombotic events.
  • Analysis of monocyte functions in arterial thrombosis and thrombolysis.
  • Synthesis of data on monocyte-thrombosis interplay in specific diseases.

Main Results:

  • Monocytes are increasingly recognized for their significant involvement in thrombosis and immune-related thrombotic diseases.
  • Specific monocyte subsets demonstrate distinct roles in the pathogenesis of cardiovascular thrombotic events.
  • Mechanisms linking monocytes to thrombosis in conditions like hypertension and atherosclerosis are being uncovered.

Conclusions:

  • Monocyte subsets are critical players in the development and progression of cardiovascular thrombotic events.
  • Targeting monocyte pathways presents a promising avenue for novel therapeutic interventions against thrombosis.
  • Further research into monocyte-thrombosis mechanisms is essential for developing effective treatment regimens.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
54.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
767
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
14
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
16
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13